EUVIMEDEUVIMED entdecken
Evaluationsstudie

Evaluation of Two Spectroscopic Techniques to Estimate the MDMA Dose of Ecstasy‐Like Tablets, an On‐Site Approach

N Meert, K Segers iD, F Van Durme, J Eliaerts

Drug Testing and Analysis · 2025

DOI: 10.1002/dta.3933 ↗

Kurz gefasst

Evaluationsstudie in der Zeitschrift Drug Testing and Analysis, 2025. Verfasst von N Meert und 3 weiteren Autor:innen. Beteiligte Einrichtung: Centre of Forensic Drug Expertise-Forensic Drugs Laboratory, National Institute for Criminalistics and Criminology, Brussels, Belgium. Hauptthemen laut MEDLINE: N-Methyl-3,4-methylenedioxyamphetamine, Hallucinogens, Illicit Drugs. Die Arbeit nennt 23 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

MDMA, commonly known as “ecstasy,” is widely used in clubs and at festivals, earning its reputation as a “party drug.” The increasing demand for rapid on‐site dose estimation of MDMA in tablets arises from the need of various stakeholders, including law enforcement, emergency services, and public health officials, to respond appropriately to potential public safety risks and incidents. This study evaluates the performance of two portable spectroscopic techniques (near‐infrared [NIR] and Fourier‐transform‐infrared [FT‐IR]) combined with chemometric modelling for estimating the MDMA dose in tablets. Ninety‐eight seized tablets were measured on‐site with both spectroscopic techniques and confirmed by the reference techniques: gas chromatography (GC) combined with a mass spectrometer (MS) and a flame‐ionization detector (FID). Considering the correlation values (NIR: R 2 = 0.64 for indirect contact with intact tablets, 0.87 for direct contact with homogenized tablets; FT‐IR: R 2 = 0.84) and the RMSEP values (NIR: 8.0 for indirect contact with intact tablets, 5.9 for direct contact with homogenized tablets; FT‐IR: 5.4), both spectroscopic techniques provide a reliable dose prediction in comparison to the GC‐FID results. Moreover, these devices are suitable for rapid on‐site application. The instruments' choice depends on several factors, such as speed, safety measures, and laboratory support for modelling. However, determining the MDMA dose does not address all health risks. Other factors, such as the presence of low‐dosed substances (undetectable on‐site) and the combination of MDMA with other drugs and/or alcohol also play a significant role. Therefore, laboratory analysis remains essential for comprehensive safety assessment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

N-Methyl-3,4-methylenedioxyamphetamineHallucinogensIllicit DrugsTabletsSpectroscopy, Fourier Transform InfraredSpectroscopy, Near-InfraredGas Chromatography-Mass SpectrometryHumansFlame Ionization

Substanzen

N-Methyl-3,4-methylenedioxyamphetamineTabletsHallucinogensIllicit Drugs

Autor:innen und Institutionen

  • Centre of Forensic Drug Expertise-Forensic Drugs Laboratory, National Institute for Criminalistics and Criminology, Brussels, Belgium.

ORCID-Profile: K Segers

Zitieren

APA

Meert, N., Segers, K., Van Durme, F., & Eliaerts, J. (2025). Evaluation of Two Spectroscopic Techniques to Estimate the MDMA Dose of Ecstasy‐Like Tablets, an On‐Site Approach. Drug Testing and Analysis. https://doi.org/10.1002/dta.3933

Vancouver

Meert N, Segers K, Van Durme F, Eliaerts J. Evaluation of Two Spectroscopic Techniques to Estimate the MDMA Dose of Ecstasy‐Like Tablets, an On‐Site Approach. Drug Testing and Analysis. 2025. doi:10.1002/dta.3933

BibTeX
@article{Meert2025,
  author = {Meert, N and Segers, K and Van Durme, F and Eliaerts, J},
  title = {Evaluation of Two Spectroscopic Techniques to Estimate the MDMA Dose of Ecstasy‐Like Tablets, an On‐Site Approach},
  journal = {Drug Testing and Analysis},
  year = {2025},
  doi = {10.1002/dta.3933}
}
Kostenlos starten →